Autor: "Wrba, F." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases.
Autorzy:: Stremitzer S; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Department of Surgery, Medical University Vienna, Vienna, Austria.
Sunakawa Y; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Zhang W; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Yang D; Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Ning Y; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Stintzing S; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Sebio A; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Yamauchi S; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Matsusaka S; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
El-Khoueiry R; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Stift J; Clinical Institute of Pathology, Medical University Vienna, Vienna, Austria.
Wrba F; Clinical Institute of Pathology, Medical University Vienna, Vienna, Austria.
Gruenberger T; Department of Surgery I, Rudolfstiftung Hospital, Vienna, Austria.
Lenz HJ; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Pokaż więcej
Źródło:: The pharmacogenomics journal [Pharmacogenomics J] 2015 Dec; Vol. 15 (6), pp. 521-9. Date of Electronic Publication: 2015 Mar 10.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Colorectal Neoplasms/*genetics
Colorectal Neoplasms/*pathology
Genes, MHC Class II/*genetics
Liver Neoplasms/*genetics
Liver Neoplasms/*pathology
Polymorphism, Single Nucleotide/*genetics
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bevacizumab/administration & dosage ; Chemotherapy, Adjuvant/methods ; Colorectal Neoplasms/drug therapy ; Disease-Free Survival ; Female ; Hepatectomy/methods ; Humans ; Liver/drug effects ; Liver/pathology ; Liver Neoplasms/drug therapy ; Male ; Middle Aged ; Neoadjuvant Therapy/methods ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Prognosis ; Survival Rate